- Home
- FIVN vs KYMR Comparison
FIVN vs KYMR Comparison
Compare FIVN & KYMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FIVN
- KYMR
- Stock Information
- Founded
- FIVN 2001
- KYMR 2015
- Country
- FIVN United States
- KYMR United States
- Employees
- FIVN N/A
- KYMR N/A
- Industry
- FIVN EDP Services
- KYMR Medicinal Chemicals and Botanical Products
- Sector
- FIVN Technology
- KYMR Health Care
- Exchange
- FIVN Nasdaq
- KYMR Nasdaq
- Market Cap
- FIVN 2.3B
- KYMR 2.2B
- IPO Year
- FIVN 2014
- KYMR 2020
- Fundamental
- Price
- FIVN $27.75
- KYMR $29.62
- Analyst Decision
- FIVN Strong Buy
- KYMR Buy
- Analyst Count
- FIVN 17
- KYMR 13
- Target Price
- FIVN $56.76
- KYMR $56.69
- AVG Volume (30 Days)
- FIVN 1.7M
- KYMR 591.0K
- Earning Date
- FIVN 05-01-2025
- KYMR 05-01-2025
- Dividend Yield
- FIVN N/A
- KYMR N/A
- EPS Growth
- FIVN N/A
- KYMR N/A
- EPS
- FIVN N/A
- KYMR N/A
- Revenue
- FIVN $1,041,938,000.00
- KYMR $47,072,000.00
- Revenue This Year
- FIVN $12.00
- KYMR $44.93
- Revenue Next Year
- FIVN $10.97
- KYMR N/A
- P/E Ratio
- FIVN N/A
- KYMR N/A
- Revenue Growth
- FIVN 14.44
- KYMR N/A
- 52 Week Low
- FIVN $26.60
- KYMR $29.07
- 52 Week High
- FIVN $63.30
- KYMR $53.27
- Technical
- Relative Strength Index (RSI)
- FIVN 28.13
- KYMR 33.94
- Support Level
- FIVN $29.04
- KYMR $29.83
- Resistance Level
- FIVN $31.78
- KYMR $35.28
- Average True Range (ATR)
- FIVN 1.23
- KYMR 1.79
- MACD
- FIVN 0.13
- KYMR -0.20
- Stochastic Oscillator
- FIVN 9.04
- KYMR 4.54
About FIVN Five9 Inc.
Five9 offers cloud-native contact center software enabling digital customer service, sales, and marketing engagement. The company's Virtual Contact Center platform combines core telephony functionality, omnichannel engagement, and various modules into a unified cloud contact-center-as-a-service, or CCaaS, platform. Five9's modules include digital self-service, agent assist technology, workflow automation, as well as workforce optimization solutions that optimize call center efficiency, and manage interaction quality and agent performance.
About KYMR Kymera Therapeutics Inc.
Kymera Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to reinventing the treatment of human disease through the development of, differentiated medicines that address health problems and that meaningfully improve patients' lives. It is committed to novel technologies to address targets that have known disease-causing biology, but which have not been drugged, or have been inadequately drugged, often based on limitations of existing technologies. Its approach is intended to discover and develop a new generation of medicines in a disease-agnostic manner. Its product pipelines are STAT6, TYK2, and IRAK4.